RENB Renovaro Inc.: Company Short-Term Debts

Symbol and logo of brand Enochian BioSciences (RENB)

Renovaro Inc. is currently restructuring its cell therapy programs following mergers, targeting the massive tumor therapy market. Total short-term debt, with chart data sourced from GURU.Markets, shows that 0.01 is hitting a new level. The financial model relies on inelastic demand and unique cell reprogramming. Investors value the brand's ambitions in AI for the creation of personalized medicine.

RENB renovarobio.com Company Short-Term Loans and Borrowings (02/21/2024 - 10/01/2025)

RENB (Renovaro Biosciences): analytical breakdowns and indicator data

- stock price and consensus target price:
Stock Price Enochian BioSciences|RENB - Consensus Target
- company stock capitalization data:
Market Capitalization Renovaro Inc.|RENB - Total Enterprise Value
- business book valuation details:
Net Assets per Single Share Renovaro|RENB - Accounting Value of Company|Market Cap to Net Assets Ratio renovarobio.com|RENB - Aggregate Asset Value
- debt and liquidity details:
Total Debt to Capital Renovaro Inc.|RENB - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Ratio Enochian BioSciences|RENB - Company Aggregate Debts|Debt to Book Capitalization Ratio Renovaro Inc.|RENB - Company Long-Term Loans and Borrowings|Company Short-Term Debts Renovaro|Quick Liquidity renovarobio.com
- earnings and multiples data:
RENB - Final Profit
Analysis of all company metrics:RENB - renovarobio.com
Manufactured products of Renovaro Inc.

Monitoring current liquidity and the ability to service obligations is critical for identifying fundamental benchmarks in the financial statements of Renovaro Inc. (RENB). An analysis of short-term debt maturing within one year, measuring the aggregate of liabilities due within twelve months, reveals capital shortage risks amid a lack of commercial products and uncertainty regarding the business model in the field of AI diagnostics.

Competing companies

BeiGene - Company Short-Term Debts|Halozyme Therapeutics, Inc. (HALO) - Company Current Liabilities|RVMD: Company Short-Term Debts|Short-Term Debt Ascentage Pharma Corp (AAPG)|Company Short-Term Debt CG Oncology, Inc.|URGN: Company Short-Term Loans and Borrowings|Company Current Liabilities BCAX (Bicara Therapeutics)|PSNL (Personalis Inc) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ERAS (Erasca Corp)|DCTH - Company Current Liabilities|YMAB: Company Current Liabilities|AURA - Company Short-Term Debts|candeltx.com (CADL) - Company Short-Term Debt|Accuray Inc - Company Short-Term Loans and Borrowings|SLS (SELLAS Life Sciences Group, Inc.) - Company Short-Term Debts|Short-Term Debt Actuate Therapeutics Inc ACTU|Company Short-Term Debt Citius Oncology, Inc. (CTOR)|HURA (tuhurabio.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debts TARA (Protara Therapeutics, Inc.)|Fate Therapeutics Inc (FATE) - Short-Term Debt|WHWK - Company Short-Term Debt|TCRX (TScan Therapeutics) - Company Short-Term Indebtedness|championsoncology.com (CSBR) - Company Short-Term Debt|Short-Term Debt XBiotech (XBIT)|Company Current Liabilities CVM|Company Short-Term Debt OSTX|Company Short-Term Debts RADX|Company Short-Term Debts artivabio.com (ARTV)|Company Short-Term Debt Adlai Nortye ANL|Company Short-Term Loans and Borrowings VERU|TPST - Company Short-Term Debt|Short-Term Debt Xilio Therapeutics, Inc.|MURA (muraloncology.com) - Company Current Liabilities|Kairos Pharma - Company Short-Term Loans and Borrowings|OKUR (OnKure Therapeutics, Inc.) - Company Short-Term Debts|CytoMed (GDTC) - Short-Term Debt Volume|Company Short-Term Debt Curis, Inc. (CRIS)|apollomicsinc.com - Company Short-Term Indebtedness|Company Short-Term Debts THAR (Tharimmune Corp)|ADVB - Company Current Liabilities|GNPX: Company Current Liabilities|Short-Term Debt Volume Calidi Biotherapeutics CLDI|Sunshine Biopharma (SBFM) - Company Short-Term Debt|Xenetic Biosciences, Inc. - Company Short-Term Loans and Borrowings|SLRX (Salarius) - Company Short-Term Debts|Short-Term Debt Kitov Pharma PPBT|Company Short-Term Debt American Oncology Network (AONC)|beigene.com - Company Short-Term Indebtedness|Company Short-Term Debts CKPT (Checkpoint Therapeutics, Inc.)|Elevation Oncology Inc. - Company Short-Term Debt|iCAD Corp - Company Short-Term Debts|Ikena Oncology, Inc. (IKNA) - Company Current Liabilities|NTBL: Company Short-Term Debts|Viracta Therapeutics, Inc. (VIRX) - Company Short-Term Debts|Company Short-Term Debt MorphoSys|Company Short-Term Indebtedness NAYA (NAYA Biosciences Inc)|Company Short-Term Debts AAPGV